Wolverine Trading’s ANI Pharmaceuticals ANIP Stock Holding History

Wolverine Trading’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,200	Closed	-$244K	–	4460
2023 Q3	$244K	Buy	+4,200	New	+$242K	﹤0.01%	3540
2022 Q2	–	Sell	-8,000	Closed	-$231K	–	4426
2022 Q1	$231K	Buy	8,000 +1,700	+27%	+$63.4K	﹤0.01%	4226
2021 Q4	$295K	Buy	+6,300	New	+$271K	﹤0.01%	4181
2018 Q4	–	Sell	-6,300	Closed	-$356K	–	4368
2018 Q3	$356K	Sell	6,300 -1,000	-14%	-$61.2K	﹤0.01%	3515
2018 Q2	$425K	Hold	7,300	–	–	﹤0.01%	3284
2018 Q1	$425K	Buy	7,300 +1,600	+28%	+$102K	﹤0.01%	3284
2017 Q4	$367K	Buy	+5,700	New	+$355K	﹤0.01%	3351
2017 Q3	–	Sell	-16,200	Closed	-$765K	–	4372
2017 Q2	$765K	Sell	16,200 -9,900	-38%	-$478K	﹤0.01%	2008
2017 Q1	$1.3M	Buy	+26,100	New	+$1.47M	0.01%	1519
2016 Q3	–	Sell	-22,700	Closed	-$1.27M	–	4569
2016 Q2	$1.27M	Buy	+22,700	New	+$1.1M	0.01%	1412

Other funds holding ANIP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's ANIP Position: Q1 2018 in Review

Wolverine Trading sold out of ANI Pharmaceuticals (ANIP) in Q1 2018, closing a stake of 7,278 shares — an estimated $462K sold.

Wolverine Trading first reported a position in ANIP in Q4 2016 and held it in 4 quarters. The position peaked at $469K in Q4 2017. 175 funds tracked by Wall St. Rank hold ANIP as of Q1 2018.

Wolverine Trading reported no remaining ANI Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Wolverine Trading sold 7,278 ANI Pharmaceuticals shares in Q1 2018, an estimated $462K.
Wolverine Trading first reported a position in ANI Pharmaceuticals in Q4 2016 and held it in 4 quarters.
Wolverine Trading's ANI Pharmaceuticals position peaked at $469K in Q4 2017.
175 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2018.

Based on Wolverine Trading's 13F filing for Q1 2018, filed 15 May 2018.